BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 31, 2005
View Archived Issues
Peregrine signs licensing agreement with Medarex for vascular targeting agents
Read More
New preclinical data support use of OXI-4503 in cancer
Read More
Inyx to acquire Celltech Manufacturing Services from UCB
Read More
EncorePharma receives phase I SBIR grant for Huntington's disease research
Read More
Acambis on track to begin phase III trials of ChimeriVax-JE by year-end
Read More
AL-208 enters phase I trials for MCI associated with CABG
Read More
Sunesis selects Aurora kinase candidate for preclinical development
Read More
New study evaluates Cotara for glioblastoma multiforme
Read More
Advaxis completes preclinical toxicology studies for Lovaxin C
Read More
SCOLR Pharma completes pilot bioavailability testing of CDT-raloxifene
Read More
Enrollment completed in phase II study of ozarelix for prostate cancer
Read More
Discovery receives FDA notification regarding Surfaxin response letter
Read More
Positive findings in open-label study of Prestara
Read More
Preclinical profile of AMG-8163 for the treatment of pain
Read More
Preclinical summary on ONO-2921, a Cav2.2 blocker for pain
Read More
Actoplus Met approved for type 2 diabetes
Read More
sBLA filed for Erbitux for head and neck cancer
Read More
New data on Remune presented
Read More
CHIR-258 active against acute myelogenous leukemia cells in vitro and in vivo
Read More
Novel BK-1 antagonist with high selectivity and good PK profile
Read More
TAK-242 subject of presentation at ACS meeting
Read More
Maraviroc reported safe and effective in HIV infection
Read More
EGIS-11229: A novel noncompetitive AMPA receptor antagonist
Read More
Case report: Reboxetine induces weight loss
Read More
Recent patents describe novel antiinfective agents
Read More
New potential treatments for obesity emerge from pharmaceutical R&D
Read More
Novel agents for thrombotic disorders imparted by AstraZeneca
Read More